Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Innoviva Inc (INVA)

12.62   -0.11 (-0.86%) 01-21 01:04
Open: 12.7 Pre. Close: 12.73
High: 12.84 Low: 12.57
Volume: 884,507 Market Cap: 1,280M
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.87 - 12.933 12.933 - 12.985
Low: 12.394 - 12.481 12.481 - 12.551
Close: 12.5 - 12.63 12.63 - 12.735

Technical analysis

as of: 2021-01-20 4:48:45 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 15.25     One year: 17.82
Support: Support1: 11.41    Support2: 10.39
Resistance: Resistance1: 13.06    Resistance2: 15.25
Pivot: 12.56
Moving Average: MA(5): 12.64     MA(20): 12.45
MA(100): 11.13     MA(250): 12.48
MACD: MACD(12,26): 0.34     Signal(9): 0.38
Stochastic oscillator: %K(14,3): 63.05     %D(3): 65.76
RSI: RSI(14): 58.95
52-week: High: 15.62  Low: 7.58  Change(%): -12.2
Average Vol(K): 3-Month: 70868  10-Days: 50218

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
INVA has closed below upper band by 42.9%. Bollinger Bands are 46% narrower than normal. The narrow width of the bands suggests low volatility as compared to INVA's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sun, 17 Jan 2021
Validea's Top Five Healthcare Stocks Based On Joel Greenblatt - 1/17/2021 - Nasdaq

Sat, 16 Jan 2021
Innoviva, Inc. (NASDAQ:INVA) Expected to Post Earnings of $0.41 Per Share - MarketBeat

Thu, 14 Jan 2021
Innoviva Inc. (INVA) Soars 5.15% on January 14 - Equities.com

Tue, 05 Jan 2021
Innoviva (NASDAQ:INVA) Upgraded at TheStreet - MarketBeat

Mon, 04 Jan 2021
Top Ranked Value Stocks to Buy for January 4th - Nasdaq

Mon, 04 Jan 2021
Is Innoviva (NASDAQ:INVA) A Risky Investment? - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 101
Shares Float (M) 54
% Held by Insiders 31.97
% Held by Institutions 75.88
Shares Short (K) 9,360
Shares Short P. Month (K) 9,410

Stock Financials

EPS 1.910
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.790
Profit Margin 67.16
Operating Margin 96.18
Return on Assets (ttm) 24.2
Return on Equity (ttm) 67.6
Qtrly Rev. Growth 34.9
Gross Profit (p.s.) 2.574
Sales Per Share 3.179
EBITDA (p.s.) 3.058
Qtrly Earnings Growth -29.10
Operating Cash Flow (M) 295
Levered Free Cash Flow (M) 183

Stock Valuations

PE Ratio 6.61
PEG Ratio
Price to Book value 2.63
Price to Sales 3.97
Price to Cash Flow 4.34

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2015-09-29
Ex-Dividend Date 2015-09-07
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.